Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-beta(3-42)
2015 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-beta(3-42)
Meissner, J. N.; Bouter, Y. & Bayer, T. A. (2015)
Journal of Alzheimer s Disease, 45(2) pp. 471-482. DOI: https://doi.org/10.3233/JAD-142868
Documents & Media
Details
- Authors
- Meissner, Julius N.; Bouter, Yvonne; Bayer, Thomas A.
- Abstract
- Pyroglutamate-modified amyloid-beta (A beta) at amino acid position three (A beta(pE3-42)) is gaining considerable attention as a potential key player in the pathogenesis of Alzheimer's disease (AD). A beta(pE3-42) is abundant in AD brain and has a high aggregation propensity, stability, and cellular toxicity. The aim of the present work was to study the effect of A beta(pE3-42) expression on neuron loss and associated behavioral deficits using the TBA42 transgenic mouse model. Expression of pyroglutamate A beta(3-42) triggers hippocampal CA1 neuron loss and behavioral deficits in the TBA42 mouse model. Mice elicited significant neuron death (-35% at the age of 12 months), deficits in the spatial reference memory, working memory, loss of anxiety, and severe motor deficits in an age-dependent manner. These results support a major pathological function of pyroglutamate A beta in AD.
- Issue Date
- 2015
- Status
- published
- Publisher
- Ios Press
- Journal
- Journal of Alzheimer s Disease
- ISSN
- 1875-8908; 1387-2877